浙江医药 (600216.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

11.9x

EV/EBITDA

5.8x

Market Cap

CNY 12.07B

MomentumView details →

1D Return

−5.14%

YTD Return

−8.51%

RSI (14)

47.5

ValuationView details →

P/E (Fwd)

11.9x

EV/EBITDA

5.8x

Market Cap

CNY 12.07B

RSI (14)

47.5

MomentumView details →

1D Return

−5.14%

YTD Return

−8.51%

ProfitabilityView details →

Gross Margin

32.53%

Net Margin

8.52%

EBITDA Margin

19.96%

ROE (TTM)

6.68%

ROA (TTM)

5.30%

Asset Turnover

0.62x

GrowthView details →

Revenue YoY

−6.03%

EPS YoY

−48.61%

FCF YoY

+42.64%

Revenue CAGR 3Y

+3.05%

EPS CAGR 3Y

+17.57%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.25

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.28

Avg Surprise (4Q)

0.00%

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

3.39x

Quick Ratio

2.54x

Div Yield

2.21%

Div Rate

CNY 0.28

Div Growth 1Y

−24.32%

Financials snapshotView financials →

Revenue (TTM)

8.82B

Net Income (TTM)

751.31M

Op. CF (TTM)

1.68B

Next earningsOct 22, 2026 →

Latest newsMore news →

China's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.8d ago

Zhejiang Medicine Co., Ltd. announced its first-half 2026 results, with net profit attributable to shareholders of 606 million yuan, down 9.99% year-on-year.10d ago

Similar companies

Sunshine Lake Pharma Co., Ltd.06887.HK 国邦医药605507.SH Elanco Animal Health IncorporatedELAN 健友股份603707.SH Consun Pharmaceutical Group Limited01681.HK Ab&B Bio Tech Co Ltd.02627.HK Find similar companies →

Latest newsMore news →

China's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.8d ago Zhejiang Medicine Co., Ltd. announced its first-half 2026 results, with net profit attributable to shareholders of 606 million yuan, down 9.99% year-on-year.10d ago